Země: Velká Británie
Jazyk: angličtina
Zdroj: VMD (Veterinary Medicines Directorate)
Oxytocin Synthetic
Kernfarm B.V.
QH01BB02
Oxytocin Synthetic
Solution for injection
POM-V - Prescription Only Medicine – Veterinarian
Cats, Cattle, Dogs, Goats, Horses, Pigs, Sheep
Hormone
Authorized
2017-05-23
Unlimited renewal: April 2023 AN: 03903/2022 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Oxytocin-S, 10 iu/ml, solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: Active substance Oxytocin acetate 0.018mg (equivalent to 10iu oxytocin at 560iu per mg) Excipient Chlorbutanol hemihydrate 5.254mg (equivalent to 5mg Chlorbutanol) For the full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Solution for Injection Clear aqueous solution 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle, horses, pigs, sheep, goats, cats and dogs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Injections with this product will initiate strong, regular and purposeful contractions of the uterine muscle especially in the later stages of pregnancy and post-partum. It also evokes the 'let-down' of milk although it has no action on the smooth muscles of the gut or urinary bladder, nor is it effective in the treatment of diabetes insipidus. The absence of vasopressor and antidiuretic effects make it particularly suitable for obstetric use (stimulation of parturition, promotion of uterine involution and control of post-partum haemorrhage) and the treatment of agalactia. The product is indicated for: - stimulation of uterine contraction to facilitate parturition in the presence of a fully dilated cervix - to promote involution of the post-parturient uterus and thus aid the passage of retained placenta - to aid in control of post-partum haemorrhage - promotion of milk 'let-down' in cases of agalactia and to facilitate ‘stripping out’ of infected quarters in the treatment of mastitis in cows. Unlimited renewal: April 2023 AN: 03903/2022 Page 2 of 5 4.3 CONTRA-INDICATIONS 1. When the product is used as an aid to parturition, cervical dilation must be confirmed prior to administration to prevent the risk of foetal death and possible uterine rupture. 2. The product is contra-indicated in any form of obstructive dystocia. 3. Excessive doses of the produ Přečtěte si celý dokument